Gregg D. Beloff

Gregg is an accomplished life science executive officer with nearly 30 years of experience leading finance and operations for both venture-backed start-ups and publicly held companies. Prior to founding Danforth Advisors, he designed and executed financial and corporate development strategies as CFO of ImmunoGen (NASDAQ: IMGN) and Archemix. He previously worked as an investment banker with Adams, Harkness & Hill, where he underwrote financings for and provided buy- and sell-side M&A counsel to biotechnology, medical device and healthcare technology companies. He began his career as a corporate attorney with Gaffin & Krattenmaker, a Boston-based law firm. Gregg also built and managed operational departments including finance and accounting, human resources, facilities, corporate communications and information systems. Select achievements include involvement in five IPOs and multiple filings, one SPAC merger, numerous private placements and three acquisitions as CFO to client companies. 

Gregg holds a BA from Middlebury College, JD from the University of Pittsburgh School of Law and MBA from Carnegie Mellon University.

Gregg is closely affiliated with Special Olympics Massachusetts including having served 11 years on the Board of Directors including 2 years as Vice Chairman and 3 years as Chairman.  Gregg also co-founded BioBall an annual biotech fundraiser that has raised over $3M for Special Olympics.